EFEMP1 and mesothelioma: Pass et al. found significant differences in fibulin-3 levels between stage I or II and stage III or IV patients.15 However, our study did not find significant differences in plasma fibulin-3 levels by mesothelioma stage, suggesting that plasma fibulin-3 may be more indicative of early mesothelial cell transformation.